Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-180-5 | CAS number: 41026-17-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The test substance did not induce an increase in gene-mutation in the Ames/Salmonella bacterial mutation test when tested up to a dose level of 5000 ug/plate with and without a rat liver S9 metabolic activation preparation.
The test substance induced a statistically significant, dose related increase in the chromosomes aberration frequency in CHO cells treated 3 -hour with metabolic activation. No statistically significant, dose related increase in the chromosomes aberration frequency in CHO cells treated 3 -hour without metabolic activation was noted.
In the LY5178Y mouse lymphoma cell gene-mutation assay, a significant, dose related increase of the TK -/- mutant frequency was noted when a 3 -hour treatment with metabolic activation or a prolonged 24 -hour treatment withh or without metabolic activation was employeed. In the study there was an increase in the frequency of small colony mutants in the test substance treated cultures that suggest a chromosome aberration mechanism.This findings in the mouse lymphoma cell mutation assay supports the positive chromosomes aberration response in CHO cell study.
The test substance,2,2-dimethylpropane-1,3-diyl cyclohex-4-ene-1,2-dicarboxylate, was evaluated for its genotoxic potential in the Comet assay to induce DNA damage inliver, stomach, and duodenumcells of male rats. At doses up to and including a dose of 2000 mg/kg/dosedid not cause a biologically significant increase in DNA damage inliver, stomach and duodenumrelative to the concurrent vehicle control. The substance was concluded to be negative (non-DNA damaging) in the in vivo Comet Assay.
Short description of key information:
The test substance was evaluated for genotoxicity potential in the
following assays: OECD 471 Bacterial (ames) mutation test, OECD 473 In
vitro chromosomes aberration Test and OECD 476 In vitro Mammalian Cell
Gene Mutation test.
Endpoint Conclusion: Adverse effect observed (positive)
Justification for classification or non-classification
Data is available from a negative OECD 489 Mammalian alkaline comet assay. There are no positive in vivo findings available, therefore no classification or labelling is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
